Novel Use Of Hydroxyurea in an African Region With Malaria

NCT01976416 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

208

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Anemia
Sickle Cell Disease
Malaria

Interventions

DRUG: Hydroxyurea
DRUG: Placebo

Sponsor

Indiana University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]